RMNCH+A approach has been launched in 2013 and it essentially looks to address the major causes of mortality among women and children as well as the delays in accessing and utilizing health care and services. The RMNCH+A strategic approach has been developed to provide an understanding of ‘continuum of care’ to ensure equal focus on various life stages.
The RMNCH+A appropriately directs the States to focus their efforts on the most vulnerable population and disadvantaged groups in the country. It also emphasizes on the need to reinforce efforts in those poor performing districts that have already been identified as the high focus districts.
Clinico-social case format for diarrhoea, demographic details, chief complaint, history of presenting illness, treatment history, past history, brief antenatal history, birth historym postnatal history, developmental history, nutrition history, immunisation history, personal history, family history, socio-economic / psycho-social history, environmental history, KAP about the disease, general examination, systemic examination, local examiantion, investigations, summary and case management.
RMNCH+A approach has been launched in 2013 and it essentially looks to address the major causes of mortality among women and children as well as the delays in accessing and utilizing health care and services. The RMNCH+A strategic approach has been developed to provide an understanding of ‘continuum of care’ to ensure equal focus on various life stages.
The RMNCH+A appropriately directs the States to focus their efforts on the most vulnerable population and disadvantaged groups in the country. It also emphasizes on the need to reinforce efforts in those poor performing districts that have already been identified as the high focus districts.
Clinico-social case format for diarrhoea, demographic details, chief complaint, history of presenting illness, treatment history, past history, brief antenatal history, birth historym postnatal history, developmental history, nutrition history, immunisation history, personal history, family history, socio-economic / psycho-social history, environmental history, KAP about the disease, general examination, systemic examination, local examiantion, investigations, summary and case management.
Important maternal and child health parameters to evaluate quality care for the special group. Includes MMR, IMR, SBR, PMR, NMR, PNMR, U5MR. Practical class for UG 4th sem
Important maternal and child health parameters to evaluate quality care for the special group. Includes MMR, IMR, SBR, PMR, NMR, PNMR, U5MR. Practical class for UG 4th sem
It heterogeneous metabolic disorder characterized by common feature of chronic hyperglycemia with disturbance of carbohydrate fat and protein metabolism.
Solid evidence on the links between preventing adolescent childbearing and alleviating poverty can motivate policymakers and donors to invest in reproductive health and family planning programs for youth. Research that documents the clear cause-and-effect relationship between program interventions and outcomes, such as better health and delayed childbearing among teens, can guide decisions about investments in research or programs.
This report examines the evidence for investing in adolescent reproductive health and family planning programs from the perspective of making an evidence-based argument to guide the investment or spending decisions of public or private organizations. Key steps in developing such an argument—a business case—include:
1. The consequences of relevant trends.
2. Evidence on the potential of particular actions or interventions to change the status quo.
3. The costs associated with different actions.
Case Study Report on PIH and Severe Pre eclampsiaRashmi Regmi
it is a case study report on PIH and Severe Pre eclampsia
I did when I was posted on Kist Medical TEaching Hospital for Midwifery Practicum
Prepared by:
Rashmi Regmi
B Sc Nursing
Manmohan Memorial Institute Of health Sciences
Taking a good history is very important in making a proper and most appropriate diagnosis.
And it is applicable to all specialties of the medical field.
Digital Clinical Experience Comprehensive (Head-to-Toe) Physi.docxmecklenburgstrelitzh
Digital Clinical Experience: Comprehensive (Head-to-Toe) Physical Assessment
Week 9 SOAP NOTE
Doris Ofodile
Walden University
Nurs 6512
Advanced Health Assessment & Diagnostic Reasoning
Dr Kristin Curcio
July 31st, 2022
Patient Initials: T.J Age: 28 Gender: Female
SUBJECTIVE DATA:
Chief Complaint (CC): " I came in because I'm required to have a recent physical exam for the
health insurance at my new job"
History of Present Illness (HPI): Miss Jones is currently employed by Smith, Steven, Stewart,
Silver & Company. Before she begins work, a pre-employment physical must be completed.
Despite having a history of type 2 diabetes, in which she is able to control it by taking metformin,
dieting, and doing physical activity. For the past 4-5 months, she has been compliant with
metformin. By eating yogurt, Metformin has no longer caused any side effects for her. The last
time she saw a doctor was for her gynecology appointment four months ago in which the doctor
prescribed oral birth control pills to her after she was diagnosed with the polycystic ovarian
syndrome. Although, according to her, she is in good health and does not have any acute health
issues, or stressful events, and is looking forward to starting her new job.
Medications: Metformin 850mg PO BID, the last dose taken this morning.
Fluticasone propionate (Flovent) was 110 milligrams twice daily.( taken last in
Albuterol (Proventil) 90mcg 2 puffs every four hours PRN.( taken three months )
Drospirenone/ethinyl estradiol (dosage unknown). It was taken this morning.
Tylenol 500 mg PO PRN for headache, medication was taken last week.
Ibuprofen 600mg PO TID PRN to alleviate period cramps, was taken six weeks ago.
Zantac was taken for GERD (completed)
Tetracycline was taken because of acne (completed)
Allergies: Miss Jones is allergic to penicillin which causes an allergic reaction characterized by
hives and a rash. She is also allergic to cats and dust which triggers an asthma attack causing her to
itch, wheeze and sneeze. She denies allergic reactions to latex and foods.
Past Medical History (PMH): During her second and a half years of life, Miss Jones was
diagnosed with asthma. Her medication regimen includes Proventil and Flovent.
A diagnosis of diabetes was made at the age of twenty-four. Metformin is the medication she uses
to manage her diabetes, but she had trouble complying because she had side effects like gassiness,
which was later relieved with yogurt. As a result, she is better able to monitor her blood sugar
levels daily, which last read at 90. The patient also reports losing 10 pounds in four months. Also,
she reported that she slipped and hit her right foot, resulting in a healed wound.
At the age of 28, she was diagnosed with the polycystic ovarian syndrome which she manages by
taking birth control pills. Miss Jone’s menstrual cycle flows for five days and is regular. No
Sexually transmitted diseases or pregnancies have been reported.
At 38.
this is the comparative case study on Choledocholithiasis with the patient admitted in TUTH Mahargunj. this presentation provide comprehensive knowledge on choledocholithiasis including its causes, pathophyisiology, clinical presentations as well as treatment modalities and nursing management.
SOAP NOTE SAMPLE FORMAT FOR MRCName LPDateTime 1315.docxrosemariebrayshaw
SOAP NOTE SAMPLE FORMAT FOR MRC
Name: LP
Date:
Time: 1315
Age: 30
Sex: F
SUBJECTIVE
CC:
“I am having vaginal itching and pain in my lower abdomen.”
HPI:
Pt is a 30y/o AA female, who is a new patient that has recently moved to Miami. She seeks treatment today after unsuccessful self-treatment of vaginal itching, burning upon urination, and lower abdominal pain. She is concerned for the presence of a vaginal or bladder infection, or an STD. Pt denies fever. She reports the itching and burning with urination has been present for 3 weeks, and the abdominal pain has been intermittent since months ago. Pt has tried OTC products for the itching, including Monistat and Vagisil. She denies any other urinary symptoms, including urgency or frequency. She describes the abdominal pain as either sharp or dull. The pain level goes as high as 8 out of 10 at times. 200mg of PO Advil PRN reduces the pain to a 7/10. Pt denies any aggravating factors for the pain. Pt reports that she did start her menstrual cycle this morning, but denies any other discharge other that light bleeding beginning today. Pt denies douching or the use of any vaginal irritants. She reports that she is in a stable sexual relationship, and denies any new sexual partners in the last 90 days. She denies any recent or historic known exposure to STDs. She reports the use of condoms with every coital experience, as well as this being her only form of contraceptive. She reports normal monthly menstrual cycles that last 3-4 days. She reports dysmenorrhea, which she also takes Advil for. She reports her last PAP smear was in 7/2016, was normal, and reports never having an abnormal PAP smear result. Pt denies any hx of pregnancies. Other medical hx includes GERD. She reports that she has an Rx for Protonix, but she does not take it every day. Her family hx includes the presence of DM and HTN.
Current Medications:
Protonix 40mg PO Daily for GERD
MTV OTC PO Daily
Advil 200mg OTC PO PRN for pain
PMHx:
Allergies:
NKA & NKDA
Medication Intolerances:
Denies
Chronic Illnesses/Major traumas
GERD
Hospitalizations/Surgeries
Denies
Family History
Father- DM & HTN; Mother- HTN; Older sister- DM & HTN; Maternal and paternal grandparents without known medical issues; 1 brother and 3 other sisters without known medical issues; No children.
Social History
Lives alone. Currently in a stable sexual relationship with one man. Works for DEFACS. Reports occasional alcohol use, but denies tobacco or illicit drug use.
ROS
General
Denies weight change, fatigue, fever, night sweats
Cardiovascular
Denies chest pain and edema. Reports rare palpitations that are relieved by drinking water
Skin
Denies any wounds, rashes, bruising, bleeding or skin discolorations, any changes in lesions
Respiratory
Denies cough. Reports dyspnea that accompanies the rare palpitations and is also relieved by drinking water
Eyes
Denies corrective lenses, blurring, visual changes of an.
Undergraduate level Presentation on Childhood Tuberculosis based on WHO guidelines, local Myanmar guidelines, Nelson Textbook of Paediatrics and WHO training modules.It would be mostly appropriate for countries with high Tuberculosis burden.
Sources specified. The original sources of some photos could not be mentioned due to space limitations. I deeply apologize for that.
Undergraduate level presentation on head injury
Includes:
Physiology & Pathophysiology
Epidemiology
Initial evaluation and management
History
Examination
Classification
Management
Outcomes
regarding head injury.
Undergraduate level presentation on Prevention of Surgical infection covering the topics of:
History
Definition
Classification
Risk factors
Surgical Site Infection (SSI)
Tetanus
Gas gangrene
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
2. FORTHIS CLINICO-SOCIAL CASE,
Case taking: Done by the whole sub-group
Presenter: Kyaw San Lin (RN - 21)
Computer: KayYu San (RN- 4)
KKThwe Sunn (RN - 1)
Kyaw San Lin (RN - 21)
Pamphlet: KKThwe Sunn (RN - 1)
3. CONTENTS
Personal Characteristics
Summary of Relevant Social & Community Aspect
Summary of Clinical Aspects
Analysis of the Problem
Management
Summary of the Case
4. PERSONAL CHARACTERISTICS
Age 29
Sex Female
Race and Religion Myanmar, Buddhist
Education 4th Standard
Marital status Married
Number of children 2
Occupation Selling rice & pickled tea (La-phat) at
Thein Phyu Night Bazaar
5. PERSONAL CHARACTERISTICS
Date ofAdmission 24th August, 2014
HospitalWard Unit 3, B Block, Central Woman Hospital
Father
Name U Sein Win
Occupation ManualWorker
Education Read &Write
Mother
Name Daw Shwe Mi
Occupation ManualWorker
Education Read & Write
6. SUMMARY OF RELEVANT SOCIAL
& COMMUNITY ASPECT
Personal History
Occupational History
Family History
Attitude towards her illness
Social Environmental History
7. PERSONAL HISTORY
Well conscious and can respond to questions
Hobby - WatchingTV, mainly movies
Doesn’t have any ambition
9. CHILDHOOD LIFE AT ZWE HTAW
VILLAGE
• Parents - poverty
• Many siblings
Born from a poor
family
• Only Elementary
school present
• Both parents can
only read and write
Primary education
at the village • Far from town
• An hour drive by
motorcycle to
nearest town Thone
khwa
For higher levels of
education…
10. LIFE EVENT AFTER MOVINGTO
YANGON CITY
Moving to
Yangon to her
elder brother at
the age of 19
Assist
household
works for her
brother’s
family
No further
Education and
health
knowledge
gained
Met her
husband-to-be
while hiring
Trishaw
11. MARRIAGE LIFE
Age of marriage – 21 yrs
After 3 yr (age of 24) – 1st child
After another 2 yr (age of 26) – 2nd child
Now, after another 3 yr (age of 29) - 3rd child pregnant
and income becomes insufficient
Lead her to sell goods at the night bazzare
12. OCCUPATIONAL HISTORY
Working hours
From 10 pm to 4 am
Abnormal sleeping
pattern
Hours of sleep per day
4 hours
Insufficient hours of
sleep
• Selling rice & pickled tea (La-phat) at Thein Phyu
Night Bazaar
13. FAMILY HISTORY
• 4 members
• Nuclear type
Her husbandPatient
2nd child1st child
14. HER HUSBAND
Age – 33 years
Education – 4th Standard
Occupation – trishaw driver
Daily income – 5000 kyats
15. HER CHILDREN
First child - 5 years old, lives with her grandparents
at Zwe Htaw village since 2012.
Second child – 3 ½ years old, sent to her
grandparents since she have the present
pregnancy
16. ATTITUDETOWARDS HER ILLNESS
According to her…
She has never worked as sex worker
No pre-marital sexual activity
No extra-marital sexual activity
Never transfused blood before
So,…
Realised that she got this disease from her beloved
husband.
Already known the chances of exposure to
premarital and extramarital sexual exposure during
his working period and environment.
17. ATTITUDETOWARDS HER ILLNESS
But,…
She understands her husband’s situation
Still loves him…
Wants to take medication regularly together with
her husband.
To get be able to live with her family happily as
normal people.
18. HER CURRENT ENVIRONMENT
Lives only with her husband in a 10 square feet room
Shared with other families.
Share bathrooms and toilets.
Transportation - easy from her house.
Bazaar - near her house and she can go easily.
Water supply - from the Gyo Phyu water pipeline.
Latrine - sanitary with septic tank attached.
Refuse disposal - in a nearby public bin.
Clinics and hospitals - situated near her house
19. SUMMARY OF CLINICAL ASPECT
History
Physical Examination
Investigations
Provisional Diagnosis
20. HISTORY
Admitted to the CentralWomen Hospital (CWH)
On 24th August, 2014
For acute gastritis and PMCT programme
21. MENSTRUAL HISTORY
Age of menarche - 13 years.
28-week cycle, lasts for 3 days, regular, moderate
amount, no dysmenorrhoea.
LMP - 3rd January, 2014 (not sure)
MBD - 33 wks 6 days
EDD - 10th October, 2014
22. PAST OBSTETRIC HISTORY
The age of marriage - 21 years.
Single marriage.
G 3, P 2+0.
Her 1st child - 5 years old, born at term by urgent
LSCS d/t APH d/t placenta praevia. No 3rd stage &
puerperal complications.
Her 2nd child - 3 ½ years old, born at term by
elective LSCS d/t previous LSCS. No 3rd stage &
puerperal complications.
23. HISTORY OF PRESENT PREGNANCY
Unplanned but wanted pregnancy.
Dx of pregnancy by UCG on March.
Signs and symptoms of pregnancy such as
morning sickness, and amenorrhoea are also
present.
Took AN care at 6th month of pregnancy at CWH.
24. HISTORY OF PRESENT ILLNESS
acute onset
dull aching pain
in epigastrium
1 day duration
aggravated by taking food
relieved by taking antacid
not severe
No radiation
25. PAST MEDICAL & SURGICAL HISTORY
No past history of H/T, DM, IHD, epilepsy,TB,
renal diseases or other diseases.
No history of hospitalization.
No past surgical history.
26. PAST GYNAECOLOGICAL HISTORY
No past gynaecological diseases, operations or
treatment.
Screening of cervical smear has not been done
before.
27. FAMILY, DRUG & PERSONAL HISTORY
No family history of H/T, DM, PE, or twin
pregnancy.
No other genetic diseases present.
No regular taking of drug.
No known drug allergy.
No smoking, alcohol drinking, betel chewing or
drugs addiction.
29. GENERAL EXAMINATION
Well alert, well orientated, lying comfortably in
the bed, no fever, slightly thin.
Eyes: Pallor present. No Jaundice.
Mouth:Teeth and gum are healthy. No tonsillar
enlargement.
Neck: No visible swelling in the neck.
Extremities
Upper limbs: NAD
Lower limbs: No clubbing, no peripheral cyanosis,
bilateral pitting petal oedema present.
30. CNS EXAMINATION
Well alert, well orientated.
Normal cranial nerves, sensory, motor and
peripheral nerves functioning.
31. CVS EXAMINATION
BP- 110/70 mmHg
PR – 70 beats/min
Apex beat - located at the left 5th ICS within the
mid-clavicular line
Normal 1st and 2nd heart sound
No added sound
34. BREAST EXAMINATION
Well developed.
Nipple is protruded.
On palpation of the four quadrants, no abnormal
lump is palpated.
35. ABDOMINAL EXAMINATION
(SUMMARY)
Fundal Height - 38week size
SFH- 35 cm
Single foetus
Longitudinal lie
Head presentation
Not engaged.
FHS is 160 beats/min, strong and regular.
36. INVESTIGATIONS
Blood for CP – RBC,WBC, & platelet are normal in
both count and morphology
Chemical Pathology – Alkaline Phosphatase↑
Infection screening
HBs Ag - negative, HCV Ab - negative, Blood for
VDRL – non-reactive
HIV screening test – reactive, 1st confirmation test –
reactive, 2nd confirmation test – Positive
HIV screening test of the husband - reactive, 1st
confirmation test – reactive, 2nd confirmation test –
Positive
CD4 count - 284 cells/𝜇L (Normal - >400 cells/𝜇L)
37. INVESTIGATIONS
USG
Date of present report 2nd July, 2014
No. of foetus: Single
Presentation: Head
Lie: Longitudinal
Placental Localization: Anterior, upper
Amniotic fluid volume: Normal
Radiologist Comments Single viable foetus
27 week at EGA
38. PROVISIONAL DIAGNOSIS
29 years old
G 3, P 2+0
at 34+6 weeks of pregnancy
with HIV infection and acute gastritis
39. ANALYSIS OFTHE PROBLEM
From 3 Aspects:
1. Social Etiology
2. Diagnoses – Clinical & Social
3. Social Implications
41. PREDISPOSING FACTORS
Poverty
Husband’s daily income - 5 thousand kyats
Low Education Level
passed only the 4th Standard
Poor Health Knowledge
not interested in seeking health knowledge
Weak Guardianship
d/t the large size of her family
needs personality formation and moral teachings
42. ENABLING FACTORS
Low education Level of Husband
Occupation of Husband
Morality of Husband, Premarital Sexual Exposure,
Unsafe Sex
Lack of Premarital Counselling
43. PRECIPITATING FACTORS
Pregnancy
increases HIV infection progression, progression to
AIDS and the chance of death.
Nature of her Occupation
weakens her health and worsens her condition.
44. REINFORCING FACTORS
Poor Nutrition
does not eat any meat other than small fish.
commonly eats vegetables → low protein diet.
Lack of Family Support
Currently, only her husband staying with her
insufficient as family support.
45. CLINICAL DIAGNOSIS
29 years old,
G 3, P 2+0,
at 33+6 weeks of pregnancy
with HIV infection and acute gastritis
48. INDIVIDUAL LEVEL
Psychological Stress
others might ignore her
socially isolated
loss of support from family & friends
emotional breakdown
fear of opportunistic infections, anticipatory grief,
shame, helplessness, and discrimination
49. FAMILY LEVEL
Increased risk of transmission of HIV
from mother to child during pregnancy, birth or lactation
Financial problems
Inability to work during pregnancy
Increase in expenditure of healthcare and health facilities
Family Burden
care given to her during gestation period → take effort
and time of family members.
Reduction of care for other children
51. NATIONAL LEVEL
Decreasing Human resources
Increased incidence and prevalence of HIV
infected person
Increased workload of health sector
52. Predisposing factors
Poverty
Low Education Level
Poor Health Knowledge
Weak Guardianship
Enabling Factors
Low education Level of
Husband
Occupation of Husband
Morality of Husband
Premarital Sexual
Exposure,
Unsafe Sex
Lack of Premarital
Counselling
Precipitating factor
Pregnancy
Nature of Occupation
Reinforcing factors
Poor Nutrition
Lack of Family Support
Clinical diagnosis
29 years old, G 3, P 2+0,
at 33+6 weeks of
pregnancy with HIV
infection & acute
gastritis
Social diagnosis
Poverty
Poor education
Lack of health
knowledge
especially in
reproductive health
Individual Level
Psychological stress
Community Level
Increased risk of
transmission
Increased workload for
doctors and medico-social
workers
Family Level
• Increased risk of
transmission of HIV
• Financial problems
• Family Burden
• Reduction of care for other
children
National Level
Decreasing Human
resources
Increased incidence and
prevalence of HIV infected
person
Increased workload of
health sector
Social Etiology
Social Implication
54. IMMEDIATE MANAGEMENTS
Individual Level
Psychological support and counselling
PMCT
Nutrition
Treatment for acute gastritis
Family Level
Counselling
Sterilization
ARV Prophylaxis to Baby
55. LONG-TERM MANAGEMENTS
Individual Level
Social support and ART treatment
Rest
Safe water and Food
Avoid handling pets
Safe Sex
Family Level
Health Education
Prevention of HIV transmission
56. COMMUNITY LEVEL
HE about blood transfusion, drug abuse, sexual
promiscuity and their disease
HE to sex workers about safe sex
Encouraging the community to help patients by
giving psychological support
Cooperation and collaboration with social
welfare services such as NGOs
57. NATIONAL LEVEL
Promoting literacy
Creating job opportunities
Promoting national health care services and facilities
National HIV/ AIDS Control Program (NAP)
Implementing PMCT programme
Surveillance against STD in community
Identify missing cases
Cooperation and collaboration with INGOs, local NGOs
and services
Supervision, monitoring and evaluation
58. SUMMARY OFTHE CASE
A female patient, aged 29, G 3, P 2+0, came to CWH for
acute gastritis and AN Care.
HIV testing done as part of the AN Care package - positive
result
Admitted to CWH, B Block, Unit 3 on 24th August, 2014 for
PMCT.
Her husband tested for HIV - positive.
Both - low income, poor educational status and lack of
reproductive health education.
59. SUMMARY OFTHE CASE
CD4 count - <350 cells/mm
ART treatment
Her husband - referred toTharketa STI Hospital for ART
treatment.
Counselling - HIV, PMCT, delivery and infant feeding